← Back to Search

Other

EVOO supplementation for Liver Transplant

N/A

Recruiting

Led By Danielle Kirkman

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline at four weeks

Awards & highlights

Study Summary

This trial aims to study how a compound called TMAO affects the heart and blood vessels in patients who have had a liver transplant and are at risk for cardiovascular disease. The goal is to find ways

Who is the study for?

This trial is for adults over 18 who speak and understand English and have received a liver transplant. It aims to explore cardiovascular health in these patients.Check my eligibility

What is being tested?

The study tests the effects of Extra Virgin Olive Oil (EVOO) on heart health in liver transplant recipients, focusing on TMAO levels—a factor linked to cardiovascular disease.See study design

What are the potential side effects?

Potential side effects are not specified, but EVOO is generally considered safe with possible minor digestive issues or allergic reactions in rare cases.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline at four weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline at four weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at four weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Serum TMAO

Secondary outcome measures

Arterial hemodynamics changes

Conduit artery endothelial function changes

Diastolic Function change

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: EVOO supplementationExperimental Treatment1 Intervention

50g/day, dietary supplementation Extra Virgin Olive Oil (EVOO)

Group II: Standard of CareActive Control1 Intervention

Standard of care control

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor

699 Previous Clinical Trials

22,885,015 Total Patients Enrolled

Danielle KirkmanPrincipal InvestigatorVirginia Commonwealth University

1 Previous Clinical Trials

15 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit for patient participation in this medical investigation?

"Indeed, as per the details on clinicaltrials.gov, this particular research investigation is actively seeking suitable participants. The trial was initially uploaded on 1/18/2024 and underwent its latest update on 3/4/2024. In total, it aims to recruit 30 patients from a single designated location."

Answered by AI

Are individuals currently eligible to participate in this ongoing clinical trial?

"Yes, data on clinicaltrials.gov indicates that this trial is actively enrolling participants. The initial posting date was January 18th, 2024, with the latest update made on March 4th, 2024. The study aims to recruit 30 subjects from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients

2024. "Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06043531.

All > Liver Transplant